USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersPerformanceEfficient FrontierCorrelationsRisk/Return

US Market Open: Sep 2, 12:50 PM 2010

NYSE 6936.34 25.36 Index Moved Up

NASDAQ 2191.06 14.22 Index Moved Up

{ and more.. }

Search is sponsered by

Financial Content Distribution

Processing
Collecting necessary data for BVF...

Biovail Corporation discussions, twits, chats, blogs, and headlines

Biovail Corporation BVF

Stock @ NYSE

Companies

SEC Records

Live Sentiment

VIRC

NGM

Bought over 500 shares of Virco Manufacturing Corp.

Few hours ago

for 2.8

TFCO

NCM

Bought over 500 shares of Tufco Technologies Inc.

Few hours ago

for 3.49

KEY-PB

NYSE

Bought over 90 shares of KEYCORP CAP VI

Few hours ago

for 20.8

SLRY

NGM

Bought over 500 shares of Salary.com Inc.

Few hours ago

for 4.08

GEF-B

NYSE

Bought over 30 shares of GREIF INC CL B

Few hours ago

for 55.25

PATK

NGM

Bought over 500 shares of Patrick Industries Inc.

Few hours ago

for 2.14

These are some of this Monday's top analyst upgrades and downgrades seen from Wall Street research calls: Anadarko Petroleum Corporation (NYSE: APC) Cut to Market Perform at FBR. Biovail Inc. (NYSE: BVF) Cut to Hold at TD.

2010-08-09

Maybe smaller Gorilla head larger BVF -or- whatever that graphic is on the sidepanel should be on the front with the stars explored a bit more. The bib front - Looks good. Bib back - design cop out - missed opportunity. ...

2010-07-21

BVF President Richard Callicott said: ?Since 2009, the BVF has faced increasing difficulties in continuing to support all of its programmes within the funding allocation made available to it by UK Sport. ...

2010-08-18

[Zacks] - The FDA has extended the review date for Glaxo and Valeant's epilepsy candidate, ezogabine, by three months.

2010-08-31

Zacks Analyst Blog Highlights: Biovail, Valeant Pharma, DeVry, Advance Auto Parts and Halliburton Company

2010-08-16

[Zacks] - Biovail Corporation's second quarter earnings of 34 cents per share comfortably surpassed the Zacks Consensus Estimate of 26 cents per share.

2010-08-13

Biovail 30-Day Moving Performance

Macroaxis Total Score

Current 30 Days Moving Rating

Current Net Investing Interest

Estimated Market Risk

1.51

actual daily

78 %

of total potential

Expected Return

0.28

actual daily

15 %

of total potential

Risk-Adjusted Return

0.18

actual daily

9 %

of total potential

Based on monthly moving average [ change ]

Increase Risk-Adjusted return of BVF by adding it to a well-diversified portfolio

Diversify

Biovail Partner Center

Get Biovail Financial Widgets

Compare To

Guess? Greif Gardner Gaylord Genesis ATP Oil Goodrich LYXOR General GE CAP GENERAL KINGSGATE GENL GENL GENERAL GEB Gabelli MORGAN AGFDF Western GDL APRIL

Risk & Return

Correlation